2009 Annual Meeting | Poster Session 03

Date Tuesday 04/28/09

Time 04:00 PM - 07:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Infections/AIDS/Prion Disease, Interventional Neurology, MS and Related Diseases, Peripheral Nerve

CME Available No CME available

Event Timeline
04:00 PM - 07:30 PM	Abstract	001 - Referral Pattern among Neurologists for Neurointerventional Procedures
04:00 PM - 07:30 PM	Abstract	002 - Necessity of Face Masks and Caps in Neurointerventional Suite Circulating Staff
04:00 PM - 07:30 PM	Abstract	003 - Contrast Nephropathy in Aneurysmal Subarachnoid Hemorrhage
04:00 PM - 07:30 PM	Abstract	004 - Stent Supported Revascularization of Acute Basilar Artery Occlusion beyond 8 Hours of Stroke Onset
04:00 PM - 07:30 PM	Abstract	005 - Quantification and Comparison of Techniques for Measuring Cerebral Vasospasm on CTA as Determined by TCD
04:00 PM - 07:30 PM	Abstract	006 - High Risk of Recurrent Ischemic Events among Patients with Deferred Endovascular Treatment for Symptomatic Intracranial Disease
04:00 PM - 07:30 PM	Abstract	007 - Late Stent Thrombosis Following Self-Expanding Intracranial Stent Placement
04:00 PM - 07:30 PM	Abstract	008 - Correlating Aspirin and Clopidogrel Platelet Function Inhibition with Clinical and Angiographic Outcome during Neuro-Interventional Procedures
04:00 PM - 07:30 PM	Abstract	009 - Intraarterial Nicardipine for Treatment of Cocaine Induced Cerebral Vasospasm and Stroke
04:00 PM - 07:30 PM	Abstract	010 - The Adjunctive Use of Intra-Arterial Eptifibatide as a Revascularization Tool in Acute Cerebrovascular Ischemia
04:00 PM - 07:30 PM	Abstract	011 - Correlation of Motor Unit Number Estimates to Histologic Fiber Counts in the Peroneal Nerve of Rabbits
04:00 PM - 07:30 PM	Abstract	012 - Using Incremental Motor Unit Number Estimation To Quantify Nerve Regeneration Following Various Methods of Surgical Repair of the Transected Rabbit Peroneal Nerve
04:00 PM - 07:30 PM	Abstract	013 - The Utility of Inching Technique in Diagnosis of Motor Nerve Conduction Block
04:00 PM - 07:30 PM	Abstract	014 - Electrodiagnostic Profile of Demyelination in Diabetic Neuropathy
04:00 PM - 07:30 PM	Abstract	015 - Safety of Nerve Conduction Studies in Individuals with Cardiac Pacemakers
04:00 PM - 07:30 PM	Abstract	016 - Repetitive Nerve Stimulation Test in Myasthenic Crisis
04:00 PM - 07:30 PM	Abstract	017 - The Value of Single Fiber Electromyography in Diagnosis of Amyotrophic Lateral Sclerosis
04:00 PM - 07:30 PM	Abstract	019 - Atypical Presentation of Multifocal Motor Neuropathy: Clinical and Neurophysiologic Data of Brazilian Male Case Report
04:00 PM - 07:30 PM	Abstract	020 - Time Course of Cortical Facilitation Following Subthalamic Deep Brain Stimulation in Parkinson's Disease
04:00 PM - 07:30 PM	Abstract	021 - Utility of Intraoperative Somatosensory and Motor Evoked Potentials in Detecting Cervical Root Avulsion
04:00 PM - 07:30 PM	Abstract	022 - Intraoperative Phrenic Nerve Somatosensory Evoked Potentials during Electrode Implanting Procedure for Chronic Motor Stimulation
04:00 PM - 07:30 PM	Abstract	023 - Botulinum Toxin Injection into the Trapezius Muscle of Cynomolgus Monkeys: Comparison of Duration of Action between Serotype A and B
04:00 PM - 07:30 PM	Abstract	024 - Comparison of the Spread of Biological Activity of Botulinum Toxin Type B and Botulinum Toxin Type A in a Monkey Model
04:00 PM - 07:30 PM	Abstract	025 - Electrophysiological and Radiological Findings in Trigeminal Neuralgia - An Attempt To Correlate
04:00 PM - 07:30 PM	Abstract	026 - Robust Response of Brain Glucose Metabolism to Short-Term Physiological Stimulation as Evaluated with Early Time Frames on FDG PET
04:00 PM - 07:30 PM	Abstract	027 - White Matter Hyperintensities on 1.5 and 3 Tesla Brain MRI in Healthy Individiuals. A Morphological and Topographic Quantitative Comparison Study
04:00 PM - 07:30 PM	Abstract	028 - Abnormal Calf Reflexes at Standard Tibial Nerve Somatosensory Evoked Potentials: An Indicator of Pyramidal Involvement in Multiple Sclerosis?
04:00 PM - 07:30 PM	Abstract	029 - The Evaluation of Brain Atrophy in Multiple Sclerosis; the Relevance of Clinical and Electrophysiological Correlates
04:00 PM - 07:30 PM	Abstract	030 - An Analysis of EEGs and Laboratory Data in ARPKD Patients for the Detection of Metabolic Abnormalities
04:00 PM - 07:30 PM	Abstract	031 - Is Lazarus' Sign a Spinal Reflex, or a Frontal Seizure?
04:00 PM - 07:30 PM	Abstract	032 - Utility of Electrocorticography for Prediction of Outcome of Temporal Lobectomy for Medically Refractory Epilepsy
04:00 PM - 07:30 PM	Abstract	033 - Cognitively Normal Oldest-Old Have Abnormal EEGs: Findings from The 90+ Study
04:00 PM - 07:30 PM	Abstract	034 - Seizure Diagnosis in the ICU: Yield with Routine EEG
04:00 PM - 07:30 PM	Abstract	035 - Acute Mental Status Changes and Subtle Periodic Epileptiform Discharges, Reversible with Bolus of Benzodiazepine Injection: Another Form of NCSE
04:00 PM - 07:30 PM	Abstract	036 - MBL Complement Pathway Activity Is Increased in Patients with Multifocal Motor Neuropathy
04:00 PM - 07:30 PM	Abstract	037 - Efficacy of Intravenous Immunoglobulin (IVIG) Treatment in Demyelinating Neuropathy Associated with Monoclonal Gammopathy of Unknown Significance (MGUS)
04:00 PM - 07:30 PM	Abstract	038 - Long-Term Maintenance Therapy with Subcutaneous Immunoglobulin in Multifocal Motor Neuropathy
04:00 PM - 07:30 PM	Abstract	039 - Anti-Ganglioside Antibodies in Multifocal Motor Neuropathy: Frequency, Specificity and Association with Weakness and Disability
04:00 PM - 07:30 PM	Abstract	040 - Anti-Ganglioside Complex IgM Antibodies in Chronic Immune Mediated Neuropathies
04:00 PM - 07:30 PM	Abstract	041 - Presence and Severity of Tremor Is Increased in IgM MGUS Neuropathy Compared to Matched Age and Neuropathy Controls
04:00 PM - 07:30 PM	Abstract	042 - Follow-Up Study and Response to Treatment in 18 Patients with Lewis-Sumner Syndrome
04:00 PM - 07:30 PM	Abstract	043 - Distal Acquired Demyelinating Sensory (DADS) Neuropathy without Anti-MAG Antibodies (Ab): A Distinct Entity?
04:00 PM - 07:30 PM	Abstract	044 - Are Biological and Electrophysiological Parameters Related to the Disability of the Patients with Polyneuropathy with Anti-MAG Antibodies?
04:00 PM - 07:30 PM	Abstract	045 - Natalizumab in the Therapy of Multifocal Motoric Neuropathy (MMN): First Case Report
04:00 PM - 07:30 PM	Abstract	046 - Chiari 1 Malformation (CM1) in Children with Neurofibromatosis 1 (NF1)
04:00 PM - 07:30 PM	Abstract	047 - Comparison of MRI Features of Inflammatory Disorders of the CNS in Children
04:00 PM - 07:30 PM	Abstract	048 - Two Unusual Clinical and Radiological Presentations of Biotinidase Deficiency
04:00 PM - 07:30 PM	Abstract	049 - Clinical and Radiological Features of Vein of Galen Malformation
04:00 PM - 07:30 PM	Abstract	050 - Loss of ETHE1, a Sulfur Mitochondrial Dioxygenase, Causes Fatal Sulfide Toxicity in Ethylmalonic Encephalopathy
04:00 PM - 07:30 PM	Abstract	051 - Covert Cerebral Infarction on MRI in a UK Based Population of Children with Sickle Cell Disease
04:00 PM - 07:30 PM	Abstract	052 - MRI Analysis of the Corpus Callosum in Siblings of Children with Autism Spectrum Disorder
04:00 PM - 07:30 PM	Abstract	053 - Small-Vessel CNS Vasculitis in Childhood: Clinical and Pathological Correlation
04:00 PM - 07:30 PM	Abstract	054 - MRI Lesion Characteristics of ADEM in Children
04:00 PM - 07:30 PM	Abstract	055 - Magnetic Resonance (MR) and Diffusion Tensor Imaging (DTI) Abnormalities in Children with Cerebellar Mutism (CM) after Posterior Fossa Tumor Resection
04:00 PM - 07:30 PM	Abstract	056 - Quantification of Neuronal Loss in Multiple Sclerosis: A PET Study with [11C]-Flumazenil
04:00 PM - 07:30 PM	Abstract	057 - CD4+CD25+Foxp3+ T Cells Are Cytotoxic for Human Neurons
04:00 PM - 07:30 PM	Abstract	058 - Remyelinated Plaques in Progressive Multiple Sclerosis Are Susceptible to 2nd Hit Active Demyelination
04:00 PM - 07:30 PM	Abstract	059 - The Killing of Neurons by Activated T Cells Is Promoted by Microglia
04:00 PM - 07:30 PM	Abstract	060 - Multifocal Myelinolysis after Rapid Correction of Hyperglycemia
04:00 PM - 07:30 PM	Abstract	061 - Gadolinium Enhancement Patterns of Tumefactive Demyelinating Lesions: Correlations with Brain Biopsy Findings and Pathophysiology
04:00 PM - 07:30 PM	Abstract	062 - Early MRI Activity during Interferon Beta-1a Therapy Predicts Response to Treatment in Patients at High Risk of Developing Clinically Definite Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	063 - Preservation of Brain Adaptive Properties Contributes to the Clinical Picture of Benign Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	064 - Disruption of the Default Mode Network in Patients with Primary Progressive and Secondary Progressive Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	065 - Contrast Enhanced Susceptibility Weighted Imaging (SWI) Increases Detection of Iron Deposition in Patients with Multiple Sclerosis. A Pilot Study
04:00 PM - 07:30 PM	Abstract	066 - T2 Hyperintensities: Extensive Screening Is Not Necessary To Determine the Diagnosis
04:00 PM - 07:30 PM	Abstract	067 - Application of an Advanced Hidden Markov Chain Approach for Automatic Quantification of Lesions Detection in a Multimodal Magnetic Resonance Imaging Approach in Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	068 - Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes
04:00 PM - 07:30 PM	Abstract	069 - Diffusion Tensor Imaging of the Corticospinal Tracts in Early Relapsing Remitting Multiple Sclerosis: Correlation of Diffusion Parameters with Motor Function
04:00 PM - 07:30 PM	Abstract	070 - Intracortical Lesion Detection by Advanced MRI Techniques and Correlation with MS Related Cognitive Impairment
04:00 PM - 07:30 PM	Abstract	071 - Natalizumab (Tysabri[reg]) Promotes Remyelination in Patients with Multiple Sclerosis. A Voxel-Wise Magnetization Transfer Imaging Case-Control Study
04:00 PM - 07:30 PM	Abstract	072 - Axial and Radial Diffusivity in Patients with Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	073 - Evidence for Enhanced Functional Activity of Cervical Cord in Primary Progressive Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	074 - Diffusion Tensor Imaging of Corpus Callosum Integrity in Multiple Sclerosis: Correlation with Disease Variables
04:00 PM - 07:30 PM	Abstract	075 - Brain MRI T1/T2 Lesion Ratio Correlates with Disability: Insight into Tissue Injury, and Implications for Trial Design and Therapeutic Strategies
04:00 PM - 07:30 PM	Abstract	076 - Consortium of Multiple Sclerosis Centers (CMSC) Guidelines for a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis: 2008 Revision
04:00 PM - 07:30 PM	Abstract	077 - Effect of Glatiramer Acetate on Microglial Activation as Measured by PET in Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	078 - The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	079 - Quality of Life in Multiple Sclerosis Is Associated with White Matter Lesion Burden and Brain Volume on Brain MRI
04:00 PM - 07:30 PM	Abstract	080 - Cortical Atrophy as a Neural Correlate of Fatigue in Multiple Sclerosis: A 3.0 T Imaging Study
04:00 PM - 07:30 PM	Abstract	081 - A Sensitive, Noise-Resistant Method for Identifying Voxel-Wise Changes in Magnetization Transfer Ratio
04:00 PM - 07:30 PM	Abstract	082 - Splenium of the Corpus Callosum Affected in Early Relapsing Remitting Multiple Sclerosis: Changes Detected with Diffusion Tensor Imaging and Thickness Measures
04:00 PM - 07:30 PM	Abstract	083 - Six-Year Prospective Multi-Voxel Brain MRS Study of Two Cohorts in RRMS To Examine the Effect of Glatiramer Acetate on Neuronal/Axonal Metabolic Injury
04:00 PM - 07:30 PM	Abstract	084 - Longitudinal Imaging of Myelin Repair and Axonal Loss in Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	085 - Rate of Change in Diffusion Tensor MRI Parameters in the Corpus Callosum in Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	086 - Dirty Appearing White Matter on 1.5 and 3 Tesla Brain MRI in Multiple Sclerosis. A Morphological Quantitative Comparison Study
04:00 PM - 07:30 PM	Abstract	087 - Semi-Automated Lesion Activity Analysis (SALAA) in Patients with Multiple Sclerosis
04:00 PM - 07:30 PM	Abstract	088 - Diagnostic Efficacy and Safety of 123I-Altropane SPECT Neuroimaging in Parkinson Syndrome (PS)
04:00 PM - 07:30 PM	Abstract	089 - Dopaminergic Denervation Pattern in Parkinson's Patients with and without Depression - A Comparative Study
04:00 PM - 07:30 PM	Abstract	090 - Quantitative Magnetic Resonance Spectroscopic Imaging in Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy
04:00 PM - 07:30 PM	Abstract	091 - Cortical Abnormalities in De-Novo Different Motor Subtypes of Parkinson's Disease: A VBM Based MR Study
04:00 PM - 07:30 PM	Abstract	092 - Cerebral Cholinergic Deficits in Parkinsonian Syndromes
04:00 PM - 07:30 PM	Abstract	093 - Comparative Value of Brain MRI and 123I-MIBG Myocardial Scintigraphy in Distinguishing amongst Lewy Body Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration
04:00 PM - 07:30 PM	Abstract	094 - Parkinson and Alzheimer-Selective Hyposmia Measures Have Different Neurochemical Substrates in Patients with Parkinson's Disease
04:00 PM - 07:30 PM	Abstract	095 - Brainstem FLAIR Hyperintensity in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17)
04:00 PM - 07:30 PM	Abstract	096 - Increased Striatal 6-[18F]Fluorodopa Uptake in Parkinson Disease with vs. without Neurogenic Orthostatic Hypotension
04:00 PM - 07:30 PM	Abstract	097 - A Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR) Magnetic Resonance Imaging (MRI) Sequence for Direct High Resolution Visualization of Subcortical Structures
04:00 PM - 07:30 PM	Abstract	098 - Effect of Bapineuzumab on MRI Measures of Cerebral Volume Change in Patients with Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	099 - Focal Reduction in Frontal White Matter Fractional Anisotropy Corresponds to Slower Processing Speed in Normal Older Adults
04:00 PM - 07:30 PM	Abstract	100 - Intracranial Volume and Brain Structure Effects on Cognition in Diverse Older Persons
04:00 PM - 07:30 PM	Abstract	101 - Thinning of the Insular Cortex in Frontotemporal Lobar Degeneration
04:00 PM - 07:30 PM	Abstract	102 - Enhanced CBF Changes by Donepezil Treatment Correlate with Cognitive Improvement in Mild Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	103 - Diffusion Tensor Imaging Characteristics of Dementia with Lewy bodies and Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	105 - Patterns and Rates of Brain Atrophy in Frontotemporal Dementia with Mutations in MAPT or PGRN
04:00 PM - 07:30 PM	Abstract	106 - Measurement of Grey Matter Water Diffusion in Frontotemporal Dementia Variants and Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	107 - Grey Matter Atrophy and Clinical Correlations in Definite Alzheimer's Disease and Lewy Body Variant AD
04:00 PM - 07:30 PM	Abstract	108 - Age-Related Decline in Visuospatial Processing Speed Is Associated with Decreased White Matter Volume in the Right Parahippocampal Region and Right Temporal Lobe
04:00 PM - 07:30 PM	Abstract	109 - 11C-PiB PET and Hippocampal Volumes Are Complementary in Distinguishing Dementia with Lewy Bodies and Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	110 - Neural Substrates for Topographical Disorientation in the Mild Cognitive Impairment: A Voxel Based Morphometry Study
04:00 PM - 07:30 PM	Abstract	111 - Memantine Treatment in Patients with Alzheimer's Disease Is Associated with a Slower Right Hippocampal Volume Loss: An Open-Label, Multi-Center Trial
04:00 PM - 07:30 PM	Abstract	112 - Spatially-Localized Hippocampal Atrophy Measures Correlate with Domain-Specific Cognitive Decline in AD and MCI
04:00 PM - 07:30 PM	Abstract	113 - Neural Correlates of Lexical-Semantic Memory in Mild Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Voxel-Based Morphometry Study
04:00 PM - 07:30 PM	Abstract	114 - Distinct Patterns of Cortical Atrophy According to Pathology in Logopenic Progressive Aphasia and Progressive Non-Fluent Aphasia
04:00 PM - 07:30 PM	Abstract	115 - Accuracy of Dementia Diagnosis: A Direct Comparison of Radiologists and a Computerized Method
04:00 PM - 07:30 PM	Abstract	116 - Diagnosis of Alzheimer's Disease by Neuroimaging: Volumetric Versus Visual Rating System
04:00 PM - 07:30 PM	Abstract	117 - Sensorimotor Network Rewiring in Patients with Mild Cognitive Impairment and Alzheimer's Disease
04:00 PM - 07:30 PM	Abstract	118 - Superficial Siderosis
04:00 PM - 07:30 PM	Abstract	119 - Symptom Presentation and CT Scan Findings of Patients with Intra-Cerebral Hemorrhage
04:00 PM - 07:30 PM	Abstract	120 - An Eye Ball Estimation of Intracerebral Hemorrhages
04:00 PM - 07:30 PM	Abstract	121 - Acute Ischemic Infarction Complicating Intracerebral Hemorrhage - Is Aggressive Blood Pressure Lowering To Blame?
04:00 PM - 07:30 PM	Abstract	122 - Radiologic Characteristics of Biopsy Definite CNS Vasculitis
04:00 PM - 07:30 PM	Abstract	123 - Stroke during Transcranial Doppler Shunt Study
04:00 PM - 07:30 PM	Abstract	124 - Temporal Progression of Silent Microbleeds in Patients with Symptomatic Cerebrovascular Disease
04:00 PM - 07:30 PM	Abstract	125 - Predictors of Stroke and Its Significance in the Outcome of Tuberculous Meningitis
04:00 PM - 07:30 PM	Abstract	126 - Ischemic Lesion Localization Due to Cardioembolic or Large Vessel Sources: Voxel Based Lesion Symptom Mapping Approach
04:00 PM - 07:30 PM	Abstract	127 - Establishing a Threshold of Hippoatenuation for Identifying the Ischemic Brain Tissue on ASPECTS Regions
04:00 PM - 07:30 PM	Abstract	128 - Sequential Magnetic Resonance Imaging Refutes the Notion That Proximal Thrombus Extension Is the Underlying Mechanism in Progresive Paramedian Lacunar Infarctions
04:00 PM - 07:30 PM	Abstract	129 - Basilar Artery Atherosclerotic Plaques in Pontine Infarction: An HR MRI Study
04:00 PM - 07:30 PM	Abstract	130 - Evaluation of Cerebrovascular Reactivity with Real Time BOLD MRI in Children
04:00 PM - 07:30 PM	Abstract	131 - Is There Any Difference of Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging? Cardioembolic Versus Atherosclerotic Occlusion
04:00 PM - 07:30 PM	Abstract	132 - Lesion Patterns, Perfusion-Diffusion Mismatch, and Lesion Growth of Border-Zone Infarcts According to Underlying Stroke Etiology
04:00 PM - 07:30 PM	Abstract	133 - Comparison of Susceptibility-Weighted Imaging (SWI) and T2-Weighted Gradient-Echo Sequence (GE) in a Prospective Series of Ten Patients with Familial Cerebral Cavernomas Angiomas (FCCM)
04:00 PM - 07:30 PM	Abstract	134 - CT Angiography and Aortic Arch Atherosclerosis
04:00 PM - 07:30 PM	Abstract	135 - Incidental Findings on Cerebral Angiography Performed for Wada Testing
04:00 PM - 07:30 PM	Abstract	136 - Initial Experience with Combined 64-Slice CT Perfusion (CTP) and CT Angiography (CTA) in Routine Practice. Potential and Pitfalls
04:00 PM - 07:30 PM	Abstract	137 - Leptomeningeal Collateral Response and Extent of Ischemic Penumbra in Patients with Acute Middle Cerebral Artery Occlusion
04:00 PM - 07:30 PM	Abstract	138 - Estimating Permeability from Perfusion Weighted Images as a Marker for Subsequent Intracranial Hemorrhage in Acute Stroke
04:00 PM - 07:30 PM	Abstract	139 - Sensitivity of CT for Detecting Posterior Fossa Infarcts
04:00 PM - 07:30 PM	Abstract	140 - MR Angiography in Ischemic Stroke Patients from North India
04:00 PM - 07:30 PM	Abstract	141 - Prior Endarterectomy Is a Predictor of the Absence of Carotid Stent Restenosis
04:00 PM - 07:30 PM	Abstract	142 - Combined Perihematomal Edema and Hematoma Volume as Predictor of Late Outcome in Patients with Spontaneous Intracerebral Hemorrhage (SICH)
04:00 PM - 07:30 PM	Abstract	143 - CT Perfusion Abnormalities in TIA Patients: A Marker of Stroke Risk
04:00 PM - 07:30 PM	Abstract	144 - Association between Carotid Plaque Burden and Large Artery Atherosclerosis in Acute Ischemic Stroke
04:00 PM - 07:30 PM	Abstract	145 - Assessment of Measurement Techniques for Degree of Stenosis of Carotid Artery
04:00 PM - 07:30 PM	Abstract	146 - Diffusion Negative FDG PETCT Positive Strokes
04:00 PM - 07:30 PM	Abstract	147 - Is Quality of MES More Important Than Its Quantity? Relative Energy Index of Microembolic Signal Better Predicts DWI Lesion Volume and Clinical Outcome of Acute Ischemic Stroke Than Frequency of Microembolic Signal Does
04:00 PM - 07:30 PM	Abstract	148 - Predictors of PEG Tube Placement in Acute Ischemic Stroke
04:00 PM - 07:30 PM	Abstract	149 - Data Mining Physiologic and Clinical Variables from Hospital Information Sets To Improve Quality of Stroke Care
04:00 PM - 07:30 PM	Abstract	150 - Right Hemisphere Stroke Patients May Present with Many and Varied Cognitive Syndromes
04:00 PM - 07:30 PM	Abstract	151 - Is the Etiological Spectrum of Embolic Stroke Changing in India? Stroke Registry-Based Study
04:00 PM - 07:30 PM	Abstract	152 - Platelet Activation in Subtypes of Acute Ischemic Stroke: A Flow Cytometry Analysis
04:00 PM - 07:30 PM	Abstract	153 - Stroke Subtypes and Risk Factors in Sri Lanka - Experience of a Stroke Unit
04:00 PM - 07:30 PM	Abstract	154 - Pure Motor Upper Limb Weakness and Infarction in the Precentral Gyrus: Mechanism of Stroke
04:00 PM - 07:30 PM	Abstract	155 - Comparison of Lacunar Infarct with Branch Atheromatous Occlusion
04:00 PM - 07:30 PM	Abstract	156 - Intravenous Thrombolysis in Cocaine Associated Ischemic Stroke
04:00 PM - 07:30 PM	Abstract	157 - Community-Acquired Bacterial Meningitis: A Five Year Experience at a University Referral Hospital
04:00 PM - 07:30 PM	Abstract	158 - Septic Encephalopathy with Multiple Microabscesses in Patient with Klebsiella Sepsis
04:00 PM - 07:30 PM	Abstract	159 - Brain Abscess Due to Uncommon Pathogens in Immunocompetent Individuals: A Perspective Study from a Developing Country
04:00 PM - 07:30 PM	Abstract	161 - Disseminated Pyomyositis: A Rare Cause of Weakness and Muscle Tenderness with Normal CK and Aldolase Levels
04:00 PM - 07:30 PM	Abstract	162 - Acute Disseminated Encephalomyelitis (ADEM): A Prospective Study on 122 Adults
04:00 PM - 07:30 PM	Abstract	163 - Reactivation of Herpes Viruses in Multiple Sclerosis Patients on Natalizumab Therapy
04:00 PM - 07:30 PM	Abstract	164 - Treatable Solitary Blindness: An Unusual Initial Manifestation of Herpes Simplex Virus Type 2 (HSV2) Meningoencephalitis in a Cancer Patient
04:00 PM - 07:30 PM	Abstract	165 - Sandfly Virus Meningoencephalitis
04:00 PM - 07:30 PM	Abstract	166 - Lyme Dementia
04:00 PM - 07:30 PM	Abstract	167 - Variant Creutzfeldt-Jakob Disease in France and the United Kingdom: Evidence for the Involvement of the Same Agent Strain
04:00 PM - 07:30 PM	Abstract	168 - What Is the Prognostic Significance of Alien Hand Sign in Creutzfeldt-Jakob Disease?
04:00 PM - 07:30 PM	Abstract	169 - Characterization of Movement Disorders in Familial Creutzfeld-Jakob Disease (fCJD)
04:00 PM - 07:30 PM	Abstract	170 - Atypical MRI and CSF Presentation in a Patient with Gerstmann-Str[auml]ussler-Scheinker Syndrome
04:00 PM - 07:30 PM	Abstract	171 - Lack of In Vivo Microglial Activation in Fatal Familial Insomnia as Revealed by [11C]-PK11195 PET
04:00 PM - 07:30 PM	Abstract	172 - Disruption of White-Matter Pathways in fCJD
04:00 PM - 07:30 PM	Abstract	173 - Diffusion Tensor Imaging in Patients with Creutzfeldt-Jakob Disease
04:00 PM - 07:30 PM	Abstract	174 - Correlation between Subcortical Atrophy and Survival of CJD Patients
04:00 PM - 07:30 PM	Abstract	175 - Potential Risk Factors for Sporadic Creitzfeldt-Jakob Disease
04:00 PM - 07:30 PM	Abstract	176 - Pro-Active Prion Exposure Risk Reduction in Patients Undergoing Brain Biopsy: It's the Cases That You Don't Suspect That Pose the Greatest Risk
06:00 PM - 07:30 PM		Break

Faculty Disclosures
Michael Grundman, MD, MPH	Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
J. Clay Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.
Joseph R. Zunt, MD	The institution of Dr. Zunt has received research support from NIH. Dr. Zunt has received publishing royalties from a publication relating to health care.
Larry Junck, MD	Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Pharmaceuticals, LLC. Dr. Junck has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bowman & Brooke.
Barbara S. Giesser, MD, FAAN	Dr. Giesser has received publishing royalties from a publication relating to health care. Dr. Giesser has a non-compensated relationship as a advisory committee member with National MS Society that is relevant to AAN interests or activities.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Steven T. DeKosky, MD, FAAN	Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Enrique C. Leira, MD, MS, FAAN	Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Henry F. McFarland, MD	Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Ryan J. Uitti, MD, FAAN	Dr. Uitti has nothing to disclose.
Jeffrey I. Frank, MD, FAAN	No disclosure on file
Harold P. Adams, Jr., MD, FAAN	The institution of Dr. Adams has received research support from NINDS.
Richard T. Moxley III, MD, FAAN	Dr. Moxley has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Andres M. Lozano, MD	Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Amer Alshekhlee, MD	No disclosure on file
Joab Chapman, MD, PhD	Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Omar A. Khan, MD, PhD	No disclosure on file
Selim R. Benbadis, MD, FAAN	Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
Claudia Kawas, MD	The institution of Dr. Kawas has received research support from NIH.
Robert P. Lisak, MD, FAAN	Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
James L. Frey, MD, FAAN	No disclosure on file
David C. Tong, MD, FAHA	No disclosure on file
Israel Steiner, MD	No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Lael Stone, MD	No disclosure on file
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Amos D. Korczyn, MD	Dr. Korczyn has nothing to disclose.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Ronald D. Chervin, MD, MS	No disclosure on file
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Vincent Thijs, MD	Dr. Thijs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Thijs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Thijs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Thijs has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Thijs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim.
Michael G. Halmagyi, MD	Dr. Halmagyi has nothing to disclose.
Brian Crum, MD	Dr. Crum has nothing to disclose.
Sid Gilman, MD, FAAN	Dr. Gilman has nothing to disclose.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Anthony J. Furlan, MD, FAAN	No disclosure on file
David S. Goldstein, MD, PhD	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Douglas S. Goodin, MD	No disclosure on file
Michael W. Weiner, MD	Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dolby Family Ventures. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuicals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoibnt. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin France. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quantum Leap Health. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sai MedPartners. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDA Corp.. Dr. Weiner has stock in Anven. Dr. Weiner has stock in Alzeca. Dr. Weiner has stock in Alzheon, Inc.. Dr. Weiner has stock in ALZpath. The institution of Dr. Weiner has received research support from NIH/NIA; National Institutes of Health/National Institutes of Aging. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Merck Sharp & Dohme. Dr. Weiner has received personal compensation in the range of $0-$499 for serving as a Speaker/Presenter with BrightFocus Foundation. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Banner Health.
Jitendra N. Sharma, MD	No disclosure on file
Latisha Sharma, MD	Dr. Sharma has nothing to disclose.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Vivien H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Camilla Blain, MD	No disclosure on file
Revere P. Kinkel, MD, FAAN	Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Nazli A. Janjua, MD, MBBS	Dr. Janjua has nothing to disclose.
Fernando D. Goldenberg, MD	Dr. Goldenberg has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal expert review.
Matthew Eccher, MD, AB, FAAN	No disclosure on file
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Sayona John, MD, FAAN	Dr. John has nothing to disclose.
Kristen A. Lindgren, MD, PhD	No disclosure on file
Catarina Quinzii Hirano, MD	No disclosure on file
Flavia B. Consens, MD	Dr. Consens has received personal compensation in the range of $500-$4,999 for serving as a Presenter at TNS meeting with Texas Neurological Society.
Nancy L. Sicotte, MD, FAAN	The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Patrick M. Grogan, MD, FAAN	No disclosure on file
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Neeraj Kumar, MD	Dr. Kumar has nothing to disclose.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Erika Driver-Dunckley, MD, FAAN	Dr. Driver-Dunckley has nothing to disclose.
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Osman Kozak, MD	No disclosure on file
Sebastian Koch, MD	Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
A J. Stoessl, MD, FAAN	No disclosure on file
Christina Caon, RN, BS	Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Erin K. O'Ferrall, MD	The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. The institution of Dr. O'Ferrall has received research support from VERTEX. The institution of Dr. O'Ferrall has received research support from Novartis. Dr. O'Ferrall has received publishing royalties from a publication relating to health care.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Rakefet Tsabari, MD	No disclosure on file
Christen L. Shoesmith, MD, BSc, FAAN	The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to AAN interests or activities.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Michael A. De Georgia, MD	Dr. De Georgia has nothing to disclose.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Samuel Ludwin, MD	No disclosure on file
William S. David, MD, PhD, FAAN	Dr. David has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dysimmune Disorders foundation. Dr. David has received publishing royalties from a publication relating to health care.
Michelle L. Mauermann, MD, FAAN	The institution of Dr. Mauermann has received research support from Intellia. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
	No disclosure on file
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Pietro Cortelli, MD, FAAN	Dr. Cortelli has nothing to disclose.
Emilien Delmont, MD	No disclosure on file
Jean-Philippe Brandel	No disclosure on file
Jean-Jacques Hauw	No disclosure on file
Andrei G. Vlassenko, MD, PhD	No disclosure on file
Mark A. Mintun, MD	Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Deborah C. Mash, PhD	No disclosure on file
Francis O. Walker, MD	No disclosure on file
Marie-Laure Welter	No disclosure on file
Denise I. Campagnolo, MD, MS	Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Shin J. Oh, MD, FAAN	No disclosure on file
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Gwendolyn C. Claussen, MD	No disclosure on file
Maria Luisa Gorno Tempini, MD, PhD	The institution of Dr. Gorno Tempini has received research support from the NIH.
Hao Zhang, PhD	No disclosure on file
Charlene R. Hoffman-Snyder, DNP	No disclosure on file
William J. Logan, MD	Dr. Logan has nothing to disclose.
Andrew M. Demchuk, MD	Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care.
Lucien Rumbach, MD	No disclosure on file
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Jean Pouget, MD, PhD	No disclosure on file
Shahram Attarian, MD, PhD	Prof. Attarian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI, Pfizer LFB, Alnylam Biogen Argenx, UCB Alexion, Astrazenica, Amicus, Janssen, Novartis, Roche. Prof. Attarian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI, Biogen,Alnylam, Argenx, USB, Alexion Astrazenica, Janssen, Roche, Amgen. The institution of Prof. Attarian has received research support from National Institut of Health .
Roberto Bergamaschi	Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Byung-Chul Lee, MD, PhD	No disclosure on file
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Annie Verschueren	No disclosure on file
Jean P. Azulay, MD	Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
William T. Hu, MD, PhD, FAAN	Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Phillippa Lavallee	No disclosure on file
Sandrine Larue, MD	No disclosure on file
Pierre Amarenco, MD	Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Amarenco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. The institution of Dr. Amarenco has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. Dr. Amarenco has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KOWA company.
Valeria Tiranti	No disclosure on file
Massimo Zeviani, MD, PhD	No disclosure on file
Francoie Sellal, MD	No disclosure on file
Luca Durelli, MD	No disclosure on file
Paola Valsasina	Paola Valsasina has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Angelo Ghezzi, MD	No disclosure on file
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Andrea Falini	No disclosure on file
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Maher Saqqur, MD	Dr. Saqqur has nothing to disclose.
Ana Piera Blabastre	No disclosure on file
Jose Miguel Santonja, MD	No disclosure on file
Hanna Rosenmann	No disclosure on file
Masharip Atadzhanov, MD, PhD, DSc, FRCP, FAAN	Dr. Atadzhanov has nothing to disclose.
Frederic Blanc	No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Sandeep Khot, MD	No disclosure on file
Richard E. Temes, MD	No disclosure on file
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
James T. Becker, PhD	No disclosure on file
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Paul W. O'Connor, MD	No disclosure on file
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Christian Wider, MD	No disclosure on file
Chong S. Lee, MD, FRCPC	Dr. Lee has nothing to disclose.
Monique M. Ryan, MD	Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen . The institution of Dr. Ryan has received research support from Save our Sons Muscular Dystrophy . The institution of Dr. Ryan has received research support from Muscular Dystrophy Australia. Dr. Ryan has received publishing royalties from a publication relating to health care.
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Alexandros L. Georgiadis, MD	No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN	The institution of Dr. Ezzeddine has received research support from NIH.
Joon-Shik Moon, MD	Dr. Moon has nothing to disclose.
Yohan Jung, MD	No disclosure on file
Fen Bao	Fen Bao has nothing to disclose.
Alexandros C. Tselis, MD, PhD	No disclosure on file
Deborah Y. Bradshaw, MD, FAAN	The institution of Dr. Bradshaw has received research support from Alexion. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Bruce R. Reed, PhD	No disclosure on file
Joel Kramer, PhD	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sami L. Khella, MD, FAAN	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
David D. Adams	David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Violaine Plante-Bordeneuve, MD	Dr. Plante-Bordeneuve has nothing to disclose.
Nobukatsu Sawamoto, MD	No disclosure on file
Robert J. Ivnik, PhD	No disclosure on file
Maria M. Shiung, BA	No disclosure on file
Afshin A. Divani, PhD	The institution of Dr. Divani has received research support from Department of Defense.
Bryan R. Ludwig, MD	Dr. Ludwig has nothing to disclose.
Brian-Fred M. Fitzsimmons, MD	No disclosure on file
Franz Fazekas, MD	No disclosure on file
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Alfred W. Sandrock, MD, PhD	No disclosure on file
Owen T. Carmichael, PhD	No disclosure on file
Gustavo Ortiz, MD	No disclosure on file
Hidehiro Mizusawa, MD, PhD	No disclosure on file
Yusei Shiga	No disclosure on file
Karine Viala	No disclosure on file
Thierry Maisonobe	No disclosure on file
Pierre Bouche, MD	No disclosure on file
Sabrina Ravaglia	No disclosure on file
Enrico Marchioni	Enrico Marchioni has nothing to disclose.
Thomas McRae	No disclosure on file
Ryuji Kaji, MD, FAAN	Dr. Kaji has nothing to disclose.
Michael Hoffmann, MD, FCP, FAHA, FAAN	No disclosure on file
Elena Moro, MD, FAAN	Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Oren S. Cohen, MD	No disclosure on file
Catherine Lubetzki	Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Richard S. Frackowiak, MD	No disclosure on file
Myeong-Kyu Kim	No disclosure on file
Lilach Ephraty	No disclosure on file
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Stephen Weigand	Stephen Weigand has nothing to disclose.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Brad Kemp	Brad Kemp has nothing to disclose.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Eleonora Tavazzi, MD	No disclosure on file
Stefano Bastianello	No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN	Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Susumu Sato, MD, FAAN	No disclosure on file
Dan M. Mungas, PhD	Dr. Mungas has nothing to disclose.
Mitsuhiro Yoshita, MD, PhD	No disclosure on file
Mustapha A. Danesi, MD	No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Jennifer Whitwell, PhD	The institution of Dr. Whitwell has received research support from NIH.
Russell L. Chin, MD	No disclosure on file
Thomas Brannagan III, MD, FAAN	Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Moira Kapral, MD	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
Robert E. Chen, MD, MBBChir	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Jerzy Slowinski	No disclosure on file
Sabina Miranda, DO	No disclosure on file
Youngbin Choi, MD	No disclosure on file
A. D. Rothner, MD	No disclosure on file
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Roger L. Albin, MD	Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex. The institution of Dr. Albin has received research support from NIH-NINDS. The institution of Dr. Albin has received research support from Parkinson's Foundation. The institution of Dr. Albin has received research support from Michael J. Fox Foundation. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as a Grant Application Reivewer with Michael J. Fox Foundation.
Warren W. Barker, MA	No disclosure on file
Francesca Bagnato, MD	Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Vasiliki N. Ikonomidou	No disclosure on file
Thomas J. Wolfe, MD	No disclosure on file
Akram Shhadeh, MD, MBA	No disclosure on file
Ranjan Duara, MD	Dr. Duara has nothing to disclose.
Najeeb S. Qadi, MD	No disclosure on file
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Peter Siao Tick Chong, MD	No disclosure on file
Ammar Al Kawi, MD, FAAN	Dr. Al Kawi has nothing to disclose.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Nicolaas I. Bohnen, MD, PhD, FAAN	Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Raymond Reichwein, MD	No disclosure on file
Robert A. Taylor, MD	No disclosure on file
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Jong S. Kim, MD, PhD	No disclosure on file
Sun U. Kwon, MD	No disclosure on file
Dong-wha Kang, MD	No disclosure on file
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Susan E. Goelz, PhD	No disclosure on file
Maria I. Aguilar, MD	Dr. Aguilar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech.
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Isabelle Klein, MD	No disclosure on file
David Wack, PhD	No disclosure on file
Wayne M. Clark, MD	Dr. Clark has nothing to disclose.
Marie-Helene Saint-Hilaire, MD, FRCPC, FAAN	Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for advarra. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson study group.
Joseph Y. Matsumoto, MD	Dr. Matsumoto has nothing to disclose.
Jessica Carpenter, MD	Dr. Carpenter has nothing to disclose.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Pramod K. Pal, MD, MBBS, DNB, DM	No disclosure on file
Peter N. Leigh, BSc, MB, FAAN	No disclosure on file
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Jennifer L. Cox, PhD	Dr. Cox has nothing to disclose.
Mark Dolev Dolgopiat, MD	No disclosure on file
Jean-Marc Leger, MD, FAAN	No disclosure on file
Ahmed E. El-Gengaihy, MD	No disclosure on file
Peter J. Koudstaal, MD	No disclosure on file
Stephen M. Graham, PhD	No disclosure on file
Isak Prohovnik, PhD	No disclosure on file
Tomas H. Holmlund, MD, FAAN	No disclosure on file
Amy Pace, ScD	No disclosure on file
Robert Hyde, PhD	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Wyatt W. Decker	No disclosure on file
Benito P. Damasceno, MD, PhD	No disclosure on file
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Anand Vaishnav, MD	No disclosure on file
John R. Lynch, MD	No disclosure on file
Dhruvil J. Pandya, MD	No disclosure on file
Ali Al-Khathaami, MD	No disclosure on file
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Thomas A. Ala, MD	No disclosure on file
Carlos S. Kase, MD, FAHA, FAAN	Dr. Kase has nothing to disclose.
Mario Mascalchi, MD	No disclosure on file
Steven L. Hoover, MD	No disclosure on file
Andrew Xavier, MD	No disclosure on file
David J. Libon, PhD	No disclosure on file
Michel Dupuis, MD	Dr. Dupuis has nothing to disclose.
Matthew J. Baker, MD	No disclosure on file
Nils Koch-Henriksen, MD	Dr. Koch-Henriksen has nothing to disclose.
Paolo Del Dotto, MD	No disclosure on file
Johannes Jakobsen, MD, DMSci	The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Seong H. Choi, MD, PhD	No disclosure on file
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
So Young Moon, MD	No disclosure on file
David Chkhartishvili, MD	No disclosure on file
Fabrizio Giuliani, MD	Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Canadian Institute of Health Research. The institution of Dr. Giuliani has received research support from University of Alberta Hospital Foundation. The institution of Dr. Giuliani has received research support from Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Novartis.
Sang B. Jeon, MD	No disclosure on file
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Scott McGinnis, MD	Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Reza Behrouz, DO, PhD, FAAN	No disclosure on file
Raphael A. Carandang, MD, FAAN	Dr. Carandang has nothing to disclose.
Richard Leigh, MD	The institution of Dr. Leigh has received research support from National Institutes of Health. The institution of Dr. Leigh has received research support from American Heart Association. Dr. Leigh has received intellectual property interests from a discovery or technology relating to health care.
Eleonora Cocco	No disclosure on file
Christian Denier	No disclosure on file
Jai Perumal, MD	Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for T G therapeutics. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Aleksandra Pikula, MD	The institution of Dr. Pikula has received research support from CIHR.
Boris Shihman, MD	No disclosure on file
Prem Kandiah, MD	Dr. Kandiah has nothing to disclose.
Ioannis Karakis, MD, FAAN	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Esra Battaloglu	Esra Battaloglu has nothing to disclose.
Jackie Durfee	No disclosure on file
Sailaja Enduri, MD	No disclosure on file
Sarah Farias	No disclosure on file
Refujia Gomez	Refujia Gomez has nothing to disclose.
Maria T. Greig Custo	No disclosure on file
Thomas Harbo	No disclosure on file
Clement Hamani	No disclosure on file
Anu Jacob, MD	Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Nilufer Kale Icen, MD	Dr. Kale has nothing to disclose.
Virginia Lee, PhD	Virginia Lee, PhD has nothing to disclose.
Pierre Lozeron	No disclosure on file
Rosa Rademakers, PhD	Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Michael Potchen	No disclosure on file
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
Andrea L. Rosso, MPH	No disclosure on file
Amrit Saxena	No disclosure on file
Yuko Shimizu, MD, PhD	Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
Audrey Strongosky	No disclosure on file
Mohamed Teleb, MD	Dr. Teleb has nothing to disclose.
Marie Theaudin, MD	No disclosure on file
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
John Ratchford, MD	Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Vita Kesner, MD, PhD, FAAN	Dr. Kesner has nothing to disclose.
Claude J. Desnuelle, MD	No disclosure on file
Peter B. Barker, MD	No disclosure on file
Udaya K. Ranawaka, MD, FRCP, FAHA, FAAN	No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Jefferson Miley, MD	No disclosure on file
Joung-Ho Rha, MD, PhD	No disclosure on file
Choong-Kun Ha, MD	No disclosure on file
Jordan Grafman, PhD	Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Antonio G. Gallo, MD	No disclosure on file
Ayman P. Tourbah	No disclosure on file
Fredric K. Cantor, MD, FAAN	No disclosure on file
Alice J. Sheffet, PhD	No disclosure on file
Susan E. Hughes	No disclosure on file
L J. Greenfield, Jr., MD, PhD, FAAN	Dr. Greenfield has received publishing royalties from a publication relating to health care.
Flavia Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Gisele Silva	Gisele Silva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Gisele Silva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UNIFESP/HIAE.
David A. Krendel, MD, FAAN	No disclosure on file
Timothy J. Ingall, MBBS, PhD	Dr. Ingall has nothing to disclose.
Rajdeep Singh, MBBS	An immediate family member of Dr. Singh has stock in Istios health. The institution of Dr. Singh has received research support from Neurona Therapeutics.
Michael Katsnelson, MD	No disclosure on file
Dan J. Gzesh, MD, FAAN	No disclosure on file
Azedeh Beheshtian, MD	No disclosure on file
Amitav Rath, Sr., MD	No disclosure on file
Sunita Venkateswaran, MD	Dr. Venkateswaran has nothing to disclose.
Elisabeth A. Cats, MD	No disclosure on file
W.Ludo Vanderpol, MD	No disclosure on file
Filippo Martinelli Boneschi	No disclosure on file
Sebastiano Bucello, MD	Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Sabrina Sacconi, MD	Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
Gianna Carla Riccitelli	No disclosure on file
Sung Rae Kim, MD	No disclosure on file
So-Hyun Kim, MD	No disclosure on file
Antonia Ceccarelli, MD, PhD	No disclosure on file
Turi Dalaker	No disclosure on file
Rana Assouad, MD	No disclosure on file
Bruno Stankoff, MD, PhD	The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Michel Bottlaender	Michel Bottlaender has nothing to disclose.
Mario Quarantelli, MD	No disclosure on file
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Ovallath Thazha K. Sujith, MD	Dr. Sujith has nothing to disclose.
Sanne Piepers	No disclosure on file
Niall Pender, PhD	No disclosure on file
Paolo Rossi	No disclosure on file
Stephan Bramow, MD	Dr. Bramow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Bethany McClenathan, MD	No disclosure on file
Mohammed S. Sanjak, PhD	No disclosure on file
Martijn Muller, PhD	No disclosure on file
Iordanis Evangelou	No disclosure on file
Elizabeth Potter, DO, PhD	No disclosure on file
Joost Raaphorst, MD	Dr. Raaphorst has nothing to disclose.
Jacqueline Rick	No disclosure on file
Giovanna Zamboni, MD	Dr. Zamboni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly . The institution of Dr. Zamboni has received research support from European Research Council.
Edward Huey	No disclosure on file
Katherine Schweitzer, MD	No disclosure on file
Kerry L. Knievel, DO, FAAN	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Clelia Pellicano, MD	No disclosure on file
Jack H. Simon, MD, PhD	No disclosure on file
Edip M. Gurol, MD	The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Brajesh K. Agrawal, MD	No disclosure on file
Pegah Afra, MD, FAAN	The institution of Dr. Afra has received research support from Neuroelectrics. The institution of Dr. Afra has received research support from Xenon Pharmaceuticals. Dr. Afra has a non-compensated relationship as a board member (representing AAN) with CoA-NDT that is relevant to AAN interests or activities.
Jale Agaoglu, MD	No disclosure on file
Piero Antuono, MD, FAAN	No disclosure on file
Shmuel Appel	No disclosure on file
Laura E. Baldassari, MD, MHS	No disclosure on file
Renata Balnyte	No disclosure on file
Marcio L. Balthazar, MD, PhD	No disclosure on file
Vikas Bansal, MD	No disclosure on file
Nisha S. Bhatia, MD	No disclosure on file
Ronald S. Black, MD	No disclosure on file
Simona Bonavita	No disclosure on file
Jean-Martin Boulanger, MD, FRCPC	No disclosure on file
Analia Calle	Analia Calle has nothing to disclose.
Dan J. Capampangan, MD, FAAN	No disclosure on file
Ellen Carl, MS	No disclosure on file
Osamah J. Choudhry	No disclosure on file
Lynn Chouhfeh, MD, FAAN	No disclosure on file
Tawnya M. Constantino, MD	No disclosure on file
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Thomas Cronin	No disclosure on file
Liying Cui, PhD	No disclosure on file
Nomazulu Dlamini, MD, PhD, MSc	No disclosure on file
Elizabeth Donner, MD, FRCPC	Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
Ramy El Khoury, MD, FAAN	No disclosure on file
Jorina Elbers, MD	No disclosure on file
Rebecca E. Matthews, MD	Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Penry Epilepsy Programs.
Adrian P. Fawcett, MD, PhD	No disclosure on file
Pamela Federighi	No disclosure on file
Kirk A. Frey, MD, PhD	No disclosure on file
Josa Frischer	No disclosure on file
Koji Fujita, MD, PhD	No disclosure on file
Sunil K. Goli, MD	No disclosure on file
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Luiz Gustavo L. Guanaes, MD	No disclosure on file
Carlos Guevara, MD	No disclosure on file
Daniel M. Harrison, MD, FAAN	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Bahareh Hassanzadeh, MD	Dr. Hassanzadeh has nothing to disclose.
Kari A. Haws	No disclosure on file
Cheryl Hemingway	Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Cheryl Hemingway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ji Hoe Heo, MD, PhD	No disclosure on file
Sylvia R. Hermans, MD	No disclosure on file
John D. Hughes, Jr., MD	No disclosure on file
Mark R. Hurtt, MD	No disclosure on file
David Y. Hwang, MD, FAAN	The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
Catalina C. Ionita, MD	No disclosure on file
Bart C. Jacobs, MD, PhD	No disclosure on file
Elysia James, MD	Dr. James has nothing to disclose.
Jayantee Kalita, MD	No disclosure on file
Amit Kansara, MD	Dr. Kansara has nothing to disclose.
Burton L. Kennedy, MD	No disclosure on file
Geoffrey A. Kerchner, MD, PhD	Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Michael Khalil	Michael Khalil has nothing to disclose.
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Terri J. Kiernan, NP	No disclosure on file
Howard L. Kim, MD	No disclosure on file
Masaki Kobayashi, MD	No disclosure on file
Irwin J. Kopin, MD	No disclosure on file
Vikas Kotagal, MD, FAAN	Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Gyanendra Kumar, MD, FAAN	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Victor Laluz	No disclosure on file
Stefan Lanker, PhD	No disclosure on file
Elad Levy	No disclosure on file
Tae Sung Lim, MD	No disclosure on file
Eric C. Lindzen, MD, PhD	No disclosure on file
Giulia Longoni, MD	Dr. Longoni has nothing to disclose.
Sandra Magalhaes	No disclosure on file
Christopher Magnano	No disclosure on file
Fumisuke Matsuo, MD, FAAN	No disclosure on file
Corey McMillan, PhD	Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Scott Millis	Scott Millis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor & Francis. The institution of Scott Millis has received research support from NIH & NIDILRR.
Usha K. Misra, MD, FAAN	No disclosure on file
Lilit Mnatsakanyan, MD	Dr. Mnatsakanyan has nothing to disclose.
J Mocco	No disclosure on file
Pradeep P. Nair, MD, DM, PDF	Dr. Nair has nothing to disclose.
Shunya Nakane, MD	No disclosure on file
Hyo Suk Nam	No disclosure on file
Michael W. Nicolle, MD	Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicolle has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms.
Yann Pereon, MD, PhD	No disclosure on file
Gunjan Parikh, MD	The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
Samip S. Patel, MD	No disclosure on file
Nicholas Phillips, MD, PhD	No disclosure on file
Alaleh Raji, MD	No disclosure on file
Venkat Ramani, MD, FAAN	No disclosure on file
Alberto Ramos, MD, FAAN	Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities.
Nishant S. Ranawat, MD	No disclosure on file
Mahmoud Rayes, MD	No disclosure on file
Jack C. Rose, MD	No disclosure on file
Jordan S. Samuels, MD	No disclosure on file
Monica Sapo	No disclosure on file
Reinhold Schmidt, MD	No disclosure on file
Nicoline Schiess, MD	Dr. Schiess has received personal compensation for serving as an employee of World Health Organization .
Claudiu Schirda, PhD	Dr. Schirda has nothing to disclose.
Megha Shah	Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Fazeel M. Siddiqui, MD	No disclosure on file
Adnan Siddiqui	Adnan Siddiqui has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott Laboratories, Acandis, Asahi Intecc Co. Ltd., Canon Medical Systems USA, Inc., Carotix Medical, LLC, CerebrovaKP, Cerenovus, Contego Medical, Inc., Cordis, Endostream Medical, Ltd (recently sold to Kaneka), FreeOx Biotech, SL, Hyperfine Operations, Inc., Imperative Care , InspireMD, Ltd., IRRAS AB, Medtronic, Minnetronix Neuro, Inc., MMI, Peijia Medical, Penumbra, Inc. Perflow Medical, Ltd., Piraeus Medical, Inc., Prometheus Therapeutics, Inc., Q'Apel Medical, Inc., Serenity Medical, Inc., Shockwave Medical, Inc., Stryker Neurovascular., Synchron Australia Pty Ltd., Tegus Medical, GmbH, T.G. Medical, Inc., Terumo Neuro (Formerly MicroVention), Unity Medical, Inc. Vastrax, LLC, Vesalio, Viz.ai, Inc., WL Gore. Adnan Siddiqui has stock in 3N Endovascular, Adona Medical, Inc., Basecamp Vascular SAS, Bend IT Technologies, Ltd., BlinkTBI, Inc, Borvo Medical, Inc., CerebrovaKP, Code Zero Medical, Inc., Cognition Medical, Collavidence, Inc., Contego Medical, Inc., CVAID Ltd., CygnusMed, E8, Inc., Endostream Medical, Ltd (Sold 2025 to Kaneka), FreeOx Biotech, SL, Galaxy Therapeutics, Inc., Hyperion Surgical, Inc., Imperative Care, Inc., InspireMD, Ltd., Instylla, Inc., IRRAS, AB, Launch NY, Inc., Neurolutions, Inc., Neurovascular Diagnostics, Inc., NeXtGen Biologics, Peijia Medical, PerFlow Medical, Ltd., Physician X, LLC, Piraeus Medical, Inc., Prometheus Therapeutics, Inc., PUMA Venture Capital Fund I, LP, Q'Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., ReNiva, Inc., Rist Neurovascular, Inc. (Purchased 2020 by Medtronic), Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Sim & Cure, Spinnaker Medical, Inc., Stent'Up, Synchron, Inc., Tegus Medical, GmbH, T.G. Medical, Inc., Tulavi Therapeutics, Inc., Vastrax, LLC,, Viseon, Inc., Viz.ai, Whisper Medical, Inc., Willow Medtech, Inc. . Adnan Siddiqui has received research support from National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic ARTISSE IDE, SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; Terumo Neuro (formerly MicroVention) FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial; . The institution of Adnan Siddiqui has received research support from Current Research Grants: Co-I for NSF 2304388 STTR Phase II: An AI-Enhanced Angiographic System to Guide Endovascular Treatment of Intracranial Aneurysms; Co-PI NIH OT2NS129366 / Medical University of South Carolina StrokeNet Thrombectomy Endovascular Platform (STEP); PI for Brain Aneurysm Foundation study titled Exploring the Relationship between Imaging- and Blood-Based Aneurysm Biomarkers and the Pathobiology of the Aneurysm Wall; PI for University of Cincinnati / NINDS FASTEST: rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time Trial;. Adnan Siddiqui has received intellectual property interests from a discovery or technology relating to health care.
Shaun O. Smart, MD	Dr. Smart has nothing to disclose.
Sung-il Sohn	No disclosure on file
Hoyon Sohn	No disclosure on file
Maria Stefanidou, MD	Dr. Stefanidou has nothing to disclose.
Cynthia M. Stonnington, MD	Dr. Stonnington has nothing to disclose.
Joyce Suhy, PhD	Dr. Suhy has nothing to disclose.
Sigal Tal, MD	No disclosure on file
Osman Tanik, MD	No disclosure on file
Nauman Tariq, MD	Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Ambooj Tiwari, MD	Dr. Tiwari has nothing to disclose.
Adam Todd, MD	No disclosure on file
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
Thanh Ton, PhD	No disclosure on file
Erik Uhlmann, MD	Dr. Uhlmann has nothing to disclose.
Meenakshsundaram Umaiorubahan, MD, FAAN	Dr. Umaiorubahan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott India Ltd. Dr. Umaiorubahan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for M/s Torrent Pharmaceuticals.
Douglas Valenta, MD	No disclosure on file
Okeanis Vaou, MD, FAAN	Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Leonard H. Verhey, PhD	No disclosure on file
Iga Wegorzewska	No disclosure on file
Jagath Wijesekera, MD, MBBS	No disclosure on file
Reva C. Wilheim	No disclosure on file
Robert G. Will, MD	No disclosure on file
Tzu-Ching Wu, MD	Dr. Wu has nothing to disclose.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Jun-Gyu Yang	No disclosure on file
Sung Y. Yu	Sung Y. Yu has received personal compensation for serving as an employee of Abbvie. Sung Y. Yu has received stock or an ownership interest from Abbvie.
George Zinkhan, MD	No disclosure on file
Shan E. Abbas, MD	Dr. Abbas has nothing to disclose.
Challa Sundaram, MD	No disclosure on file
Begona Lopes Pesquera, MD	No disclosure on file
Adetolu Odufye	No disclosure on file
Daniela Perani	No disclosure on file
Alejandro Ponz De Tienda, MD	No disclosure on file
Hitoshi Shinoto, MD, FAAN	Dr. Shinoto has nothing to disclose.
Massimiliano Calabrese	Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Massimiliano Calabrese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. The institution of Massimiliano Calabrese has received research support from Roche.
Feza Deymeer, MD	No disclosure on file
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Avner Thaler, MD	The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Maria C. Sam, MD, FAAN	Dr. Sam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive Therapeutics, Inc.
Ratnavalli Ellajosyula, MD, DM, FAAN	Dr. Ellajosyula has nothing to disclose.
Jihad S. Inshasi, MD, MBBS, FAAN	Dr. Inshasi has nothing to disclose.
Alberto Villarejo Galende	Alberto Villarejo Galende has nothing to disclose.
Marina Scarlato	No disclosure on file
Francesca Sangalli	No disclosure on file
Shawn C. Aylward, MD	Dr. Aylward has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. The institution of Dr. Aylward has received research support from Pfizer. Dr. Aylward has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Vaccine injury counsel.
Tarannum Khan, MD, MBBS, FAAN	Dr. Khan has nothing to disclose.
Alfred T. Frontera, Jr., MD	Dr. Frontera has nothing to disclose.
Katya Rascovsky	No disclosure on file
Katrina Peariso, MD, PhD	No disclosure on file
Shannon M. DiCarlo, MD, FAAN	Dr. DiCarlo has nothing to disclose.
Christopher Y. Way, DO	No disclosure on file
Alexandra Tomic	No disclosure on file
Ivan Adamec	Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jadran Galenski laboratorij. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Phoenix farmacija.
Lindsay N. Alfano, PT	Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Alexander J. Beagle	No disclosure on file
Fahd Amjad, MD	Dr. Amjad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Amjad has received personal compensation in the range of $0-$499 for serving as a Consultant for abbvie. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowna Kirin. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for This information is included in the consultant disclosure. The institution of Dr. Amjad has received research support from Roche.
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Leslie J. Roberts, MD	No disclosure on file
Abbas Jowkar, MD	No disclosure on file
David Doan, MD	No disclosure on file
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Maria Russo	No disclosure on file
Robert I. Thompson-Stone, MD, FAAN	Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: ��ɫ�� Journal that is relevant to AAN interests or activities.
Sol T. De Jesus, MD	Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc. Dr. De Jesus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc.
Jonathan J. Ong, MD	No disclosure on file
Riadh Gouider, MD, FAAN	Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Priya Dhawan, MD	Dr. Dhawan has nothing to disclose.
Patricio Chrem Mendez, MD	Dr. Chrem Mendez has nothing to disclose.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Anna-Marieta Moise, MD	No disclosure on file
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Dobri Baldaranov, MD	No disclosure on file
Gloria Kim	No disclosure on file
Ines Kobor	No disclosure on file
Nelleke C. Van Wouwe, PhD	No disclosure on file
Niccolò Mencacci	No disclosure on file
Puja A. Joshi, MD	No disclosure on file
Siw Johannesen, MD	No disclosure on file
Suhas Bajgur, MD	Dr. Bajgur has nothing to disclose.
Youssef Sidhom, MD	Dr. Sidhom has nothing to disclose.
Martin E. Brown, MD	Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with University of Louisville.
Elisabeth J. Rushing, MD	No disclosure on file
Denis Sablot, MD	No disclosure on file
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Ping-Ru T. Ko, MD	No disclosure on file
Fahad S. Al-Ajlan, MD	Dr. Al-Ajlan has nothing to disclose.
Sunita N. Misra, MD	Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.
Konstantinos Kioulachidis, MD	No disclosure on file
Ellen Valadez, MD	No disclosure on file
Cory J. Kogelschatz, MD	No disclosure on file
Elana Pinchefsky, MD	No disclosure on file
Deborah Gustafson, PhD, MS	The institution of Deborah Gustafson, PhD, MS has received research support from National Institutes of Health.
Eric J. Arehart, MD	No disclosure on file
Fariha Khalid, MD	No disclosure on file
Renxin Chu	Dr. Chu has nothing to disclose.
Sheena Dupuy	No disclosure on file
Sara H. Duffus	No disclosure on file
Sonya Bakshi	No disclosure on file
Vanessa Wiggermann	No disclosure on file
Yi Shiau Ng	No disclosure on file
Arnaud Saj	No disclosure on file
Susanne Philippi, PhD	No disclosure on file
Vera E. Crone, MBBS	No disclosure on file
Mariel Pullman, MD	The institution of Dr. Pullman has received research support from Empire Clinical Research Investigator Program.
Jan Bardon	No disclosure on file
Cheng-Te Lin	No disclosure on file
Christine Saint-Martin	No disclosure on file
Jaime Hatcher-Martin, MD, PhD, FAAN	Dr. Hatcher-Martin has received personal compensation for serving as an employee of Synapticure. Dr. Hatcher-Martin has received personal compensation for serving as an employee of HD Genetics. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Science37. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Hatcher-Martin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hatcher-Martin has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npc Parkinson's Disease Journal.
Mehmet Demirci, MD	No disclosure on file
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Mohammad I. Alhatou, MD	Dr. Alhatou has nothing to disclose.
Roongroj Bhidayasiri, MD, FRCP, FRCPI, FAAN	No disclosure on file
Roelien H. Enting, MD	No disclosure on file
Kevin O'brien	No disclosure on file
Ayse Nur Yuceyar, MD	No disclosure on file
Natalie Gillson, MD	No disclosure on file
David T. Nguyen, DO	No disclosure on file
Ali M. Bayan, MD	No disclosure on file
Fereshteh N. Behdani, MD	No disclosure on file
Marzena Pedrini, PhD	Dr. Pedrini has nothing to disclose.
Aaron M. Gusdon, MD	The institution of Dr. Gusdon has received research support from NINDS.
Nouf S. Al Talai, MD	No disclosure on file
Justin Rossi	No disclosure on file
Francisco E. Gomez III, MD	No disclosure on file
Arth K. Srivastava, MD	No disclosure on file
Shima Bozorgui, MD	Dr. Bozorgui has nothing to disclose.
Emil K. Gustavsson	No disclosure on file
Lauren Kett, MD, PhD	Dr. Kett has received personal compensation for serving as an employee of Amylyx Pharmaceuticals. Dr. Kett has or had stock in Amylyx Pharmaceuticals.Dr. Kett has or had stock in Vertex Pharmaceuticals.
Seung Min Kim	Seung Min Kim has received research support from Veterans Health Service Medical Center Research Grant.
Andreas Lutterotti	No disclosure on file
Natalia T. Mendes, MD	Dr. Mendes has nothing to disclose.
Irene Pulido-Valdeolivas	No disclosure on file
Keli Tahara, MD	Dr. Tahara has nothing to disclose.
Joanne Trinh	Ms. Trinh has received personal compensation for serving as an employee of synlab. Ms. Trinh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for acurex.

��ɫ����

��ɫ����

��ɫ��

��ɫ��